These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2769668

  • 1. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases.
    Seibel MJ, Duncan A, Robins SP.
    J Rheumatol; 1989 Jul; 16(7):964-70. PubMed ID: 2769668
    [Abstract] [Full Text] [Related]

  • 2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 3. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
    Seibel MJ, Woitge H, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, Ziegler R, Robins SP.
    J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
    [Abstract] [Full Text] [Related]

  • 4. Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis.
    Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda Y, Azuma Y, Ohta T, Ochi T, Nishizawa Y, Morii H.
    J Rheumatol; 2000 Jan; 27(1):64-70. PubMed ID: 10648019
    [Abstract] [Full Text] [Related]

  • 5. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 6. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
    St Clair EW, Moak SA, Wilkinson WE, Sanders L, Lang T, Greenwald RA.
    J Rheumatol; 1998 Aug; 25(8):1472-9. PubMed ID: 9712086
    [Abstract] [Full Text] [Related]

  • 7. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.
    Wong PK, Young L, Vaile JH, Tan L, Bertouch JV, Bleasel JF, White C.
    Intern Med J; 2004 Aug; 34(9-10):539-44. PubMed ID: 15482266
    [Abstract] [Full Text] [Related]

  • 8. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.
    Robins SP, Stewart P, Astbury C, Bird HA.
    Ann Rheum Dis; 1986 Dec; 45(12):969-73. PubMed ID: 3813668
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ.
    J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
    [Abstract] [Full Text] [Related]

  • 10. Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis.
    Graverand MP, Tron AM, Ichou M, Dallard MC, Richard M, Uebelhart D, Vignon E.
    Br J Rheumatol; 1996 Nov; 35(11):1091-5. PubMed ID: 8948294
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 12. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ.
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [Abstract] [Full Text] [Related]

  • 13. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH, Altman RD, Williams JM, Devogelaer JP, Druetz-Van Egeren A, Lenz ME, Pietryla D, Thonar EJ.
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases.
    Müller A, Jakob K, Hein GE.
    Ann Rheum Dis; 2003 Jan; 62(1):65-7. PubMed ID: 12480673
    [Abstract] [Full Text] [Related]

  • 15. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 16. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP.
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [Abstract] [Full Text] [Related]

  • 17. Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis.
    Cremers SC, Lodder MC, Den Hartigh J, Vermeij P, Van Pelt P, Lems WF, Papapoulos SE, Dijkmans BA.
    J Rheumatol; 2004 Sep; 31(9):1732-7. PubMed ID: 15338492
    [Abstract] [Full Text] [Related]

  • 18. Hydroxypyridinium collagen crosslinks in serum, urine, synovial fluid and synovial tissue in patients with rheumatoid arthritis compared with osteoarthritis.
    Kaufmann J, Mueller A, Voigt A, Carl HD, Gursche A, Zacher J, Stein G, Hein G.
    Rheumatology (Oxford); 2003 Feb; 42(2):314-20. PubMed ID: 12595629
    [Abstract] [Full Text] [Related]

  • 19. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.
    Hein G, Franke S, Müller A, Bräunig E, Eidner T, Stein G.
    Clin Rheumatol; 1997 Mar; 16(2):167-72. PubMed ID: 9093799
    [Abstract] [Full Text] [Related]

  • 20. The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis.
    Dílek K, Alí I, Göksal K, Hüseyin T, Güner T.
    Yonsei Med J; 2002 Aug; 43(4):435-40. PubMed ID: 12205730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.